FDA Medical Device Recalls (openFDA)
Insulet Corporation: Omnipod 5 Automated Insulin Delivery System
- Recall number
- Z-2618-2023
- Recalling firm
- Insulet Corporation
- Product
- Omnipod 5 Automated Insulin Delivery System
- Status
- Open, Classified
- Initiated
- 2023-02-28
- Posted
- 2023-09-20
- Terminated
- not on file
- Reason
- An error message was received when using the Omnipod 5 App on compatible smartphones that prevented phone control users from controlling the Omnipod 5 Automated Insulin Delivery System from their Omnipod 5 App which may cause a delay in therapy. To reduce the volume of inquiries Insulet was receiving from customers, an email was sent to all phone control users and the cause of the error message was resolved by reverting to prior certificates on the Insulet cloud to secure communications between the Omnipod 5 App sotware and the Insulet Cloud. This issue was limited to only certain compatible Android smartphones and did not affect the Omnipod 5 Pods or the dedicated locked-down Controller provided by Insulet. All other Omnipod 5 users were still able to manage their insulin with the device without use of the smartphone app and affected users were able to switch to the locked-down control provided to all users when they initiated the device during the time the App was unavailable to them. Further, the Omnipod itself continued to deliver insulin as per its pre-programmed settings so although affected users who did not have the locked-down controller readily available may not have been able to command insulin boluses during this time, they continued to receive basal insulin without interruption. Lastly, users of the Omnipod 5 were advised during training to always have backup supplies ready in the event of a device malfunction which would include alternative means to deliver insulin subcutaneously until the issue is resolved to minimize disruption to their insulin regimen. There were 2,168 complaints received out of 7,838 users with the Android compatible smartphones affected and 9 MDRs were submitted, however, there were no serious injuries reported or reports of erroneous results as the primary issue was a delay in therapy. This defect cannot cause false results that could negatively impact patients.
- Root cause
- Software Design Change
- Action
- Insulet emailed all phone control users on February 28, 2023 that an investigation into the issue was underway. Insulet determined root cause and resolved the issue early on March 1, 2023. Insulet sent a follow up email to all phone control users on March 1 to notify them that the issue had been resolved.
- Quantity
- 11,016 users
- Distribution
- Distribution throughout the US
- Lot, serial or model codes
- PT-000559 Omnipod 5 App; all versions of software installed UDI-DI: 10385081120302
- 510(k) numbers
- ["K203768"]
- PMA numbers
- not on file
- Product code
- QFG
- Firm FEI
- 3014585508
- Firm city
- Acton
- Firm state
- MA
- Firm country
- not on file
Where this comes from
- Register
- FDA Medical Device Recalls (openFDA)
- Publisher
- U.S. Food and Drug Administration (openFDA)
- File
- device-recall-0001-of-0001.json.zip
- sha256
- b87518bfe2e8
- Size
- 288210821 bytes
- Published
- 2026-09-28
- Read
- 2026-09-29T08:25:23.626Z
- Source file
- Source file retained · verify
- Refresh due
- 2026-10-06
Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.
Cite as
FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28